Literature DB >> 26176353

A Pragmatic Approach to the Management of Dry Eye Disease: Evidence into Practice.

Laura E Downie1, Peter R Keller.   

Abstract

Dry eye disease (DED) is a highly prevalent chronic ocular disorder that can lead to significant discomfort and visual disturbance. It is a potentially debilitating condition that can have significant negative impact on quality of life. A diverse range of management options exists for DED, including tear supplement products, anti-inflammatory agents, immunomodulators, punctal occlusive devices, and environmental modifiers. Although the availability of a variety of treatment approaches provides clinical flexibility and can enable individualized care, it can also complicate clinical management decisions and lead to variability in the nature of the clinical care provided to patients. By considering two dry eye case scenarios, this review evaluates the currently available evidence relating to DED therapy to describe a pragmatic clinical approach to best-practice management of dry eye patients.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26176353     DOI: 10.1097/OPX.0000000000000653

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  8 in total

1.  Omega-3 and omega-6 polyunsaturated fatty acids for dry eye disease.

Authors:  Laura E Downie; Sueko M Ng; Kristina B Lindsley; Esen K Akpek
Journal:  Cochrane Database Syst Rev       Date:  2019-12-18

2.  α-Melanocyte-stimulating hormone ameliorates ocular surface dysfunctions and lesions in a scopolamine-induced dry eye model via PKA-CREB and MEK-Erk pathways.

Authors:  Yusha Ru; Yue Huang; Huijuan Liu; Juan Du; Zhu Meng; Zexia Dou; Xun Liu; Rui Hua Wei; Yan Zhang; Shaozhen Zhao
Journal:  Sci Rep       Date:  2015-12-21       Impact factor: 4.379

3.  Evaluation of a new artificial tear formulation for the management of tear film stability and visual function in patients with dry eye.

Authors:  Gail Torkildsen; Mile Brujic; Michael S Cooper; Paul Karpecki; Parag Majmudar; William Trattler; Meryl Reis; Joseph B Ciolino
Journal:  Clin Ophthalmol       Date:  2017-10-19

Review 4.  False Myths versus Medical Facts: Ten Common Misconceptions Related to Dry Eye Disease.

Authors:  Giuseppe Giannaccare; Vincenzo Scorcia
Journal:  Biomedicines       Date:  2020-06-24

5.  Real-life results of switching from preserved to preservative-free artificial tears containing hyaluronate in patients with dry eye disease.

Authors:  Linda Nasser; Malgorzata Rozycka; Gabriela Gomez Rendon; Alejandro Navas
Journal:  Clin Ophthalmol       Date:  2018-08-23

Review 6.  Prevalence of dry eye disease in visual display terminal workers: a systematic review and meta-analysis.

Authors:  Romain Courtin; Bruno Pereira; Geraldine Naughton; Alain Chamoux; Frédéric Chiambaretta; Charlotte Lanhers; Frédéric Dutheil
Journal:  BMJ Open       Date:  2016-01-14       Impact factor: 2.692

7.  Comparison of 0.1%, 0.18%, and 0.3% Hyaluronic Acid Eye Drops in the Treatment of Experimental Dry Eye.

Authors:  In Cheon You; Ying Li; Rujun Jin; Min Ahn; Won Choi; Kyung Chul Yoon
Journal:  J Ocul Pharmacol Ther       Date:  2018-07-23       Impact factor: 2.671

8.  In Vivo Anti-Inflammation Potential of Aster koraiensis Extract for Dry Eye Syndrome by the Protection of Ocular Surface.

Authors:  Sung-Chul Hong; Jung-Heun Ha; Jennifer K Lee; Sang Hoon Jung; Jin-Chul Kim
Journal:  Nutrients       Date:  2020-10-23       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.